CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, 1138
N. diseases: 110; N. variants: 40
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
15 | 78580777 | intron variant | C/G;T | snv | 0.34 |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 2 | 2010 | 2010 | |||||||||
|
15 | 78580777 | intron variant | C/G;T | snv | 0.34 |
|
0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||||
|
15 | 78580777 | intron variant | C/G;T | snv | 0.34 |
|
0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Chemically-Induced Disorders; Mental Disorders | 0.100 | 1.000 | 29 | 2008 | 2018 | ||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Neoplasms; Respiratory Tract Diseases | 0.100 | 0.963 | 27 | 2008 | 2018 | ||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Neoplasms; Respiratory Tract Diseases | 0.100 | 0.963 | 27 | 2008 | 2018 | ||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Neoplasms; Respiratory Tract Diseases | 0.100 | 0.963 | 27 | 2008 | 2018 | ||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Respiratory Tract Diseases | 0.780 | 0.889 | 9 | 2010 | 2018 | ||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Neoplasms | 0.030 | 0.667 | 3 | 2010 | 2017 | ||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 3 | 2010 | 2012 | ||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Mental Disorders | 0.030 | 1.000 | 3 | 2011 | 2019 | ||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Neoplasms | 0.030 | 0.667 | 3 | 2010 | 2017 | ||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2009 | 2010 | ||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Chemically-Induced Disorders; Mental Disorders | 0.020 | 1.000 | 2 | 2008 | 2010 | ||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Cardiovascular Diseases | 0.010 | < 0.001 | 1 | 2015 | 2015 | ||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
0.700 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Behavior and Behavior Mechanisms | 0.010 | < 0.001 | 1 | 2014 | 2014 | ||||||
|
0.653 | 0.360 | 15 | 78590583 | missense variant | G/A | snv | 0.26 | 0.24 |
|
Neoplasms; Stomatognathic Diseases | 0.010 | < 0.001 | 1 | 2014 | 2014 |